Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,830
+50 (0.46%)
Last updated: Jun 5, 2025
31.27%
Market Cap 229.92B
Revenue (ttm) 217.69B
Net Income (ttm) -12.97B
Shares Out 21.23M
EPS (ttm) -661.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 139,016
Average Volume 133,006
Open 10,720
Previous Close 10,780
Day's Range 10,650 - 11,150
52-Week Range 7,910 - 19,500
Beta 0.39
RSI 34.77
Earnings Date May 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.